Siplizumab Biosimilar – Anti-CD2, LFA-2 mAb – Research Grade

Reference:
Product nameSiplizumab Biosimilar - Anti-CD2, LFA-2 mAb - Research Grade
SourceCAS 288392-69-8
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsSiplizumab,MEDI-507,CD2, LFA-2,anti-CD2, LFA-2
ReferencePX-TA1051
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

SDS-PAGE for Siplizumab Biosimilar - Anti-CD2, LFA-2 mAb

Siplizumab Biosimilar - Anti-CD2, LFA-2 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Siplizumab Biosimilar – Anti-CD2, LFA-2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD2 Recombinant Protein
Antigen

CD2 Recombinant Protein

PX-P4073 326$
CD223 Recombinant Protein
Antigen

CD223 Recombinant Protein

PX-P4110 326$
CD257 Recombinant Protein
Antigen

CD257 Recombinant Protein

PX-P4112 426$
CD276 Recombinant Protein
Antigen

CD276 Recombinant Protein

PX-P4125 326$
Human CX3CR1 recombinant protein
Antigen

Human CX3CR1 recombinant protein

PX-P4093 326$
Human CD270,TNFRSF14,HVEM recombinant protein
Antigen

Human CD270,TNFRSF14,HVEM recombinant protein

PX-P4039 221$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 189$
Stable Isotope Labelled Siplizumab Biosimilar – Anti-CD2/LFA-2 mAb – Research Grade
SIL

Stable Isotope Labelled Siplizumab Biosimilar – Anti-CD2/LFA-2 mAb – Research Grade

PX-TA1051-SIL 15750$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products